MedPath

HADASSAH MEDICAL ORGANIZATION (CC)

๐Ÿ‡ฎ๐Ÿ‡ฑIsrael
Ownership
-
Employees
-
Market Cap
-
Website

Derivation of Induced Pluripotent Stem Cells From an Existing Collection of Human Somatic Cells

Recruiting
Conditions
Amyotrophic Lateral Sclerosis
First Posted Date
2008-12-03
Last Posted Date
2025-03-05
Lead Sponsor
Hadassah Medical Organization
Target Recruit Count
25
Registration Number
NCT00801333
Locations
๐Ÿ‡ฎ๐Ÿ‡ฑ

Hadassah Medical Organization - Ein Kerem Campus, Jerusalem, Israel

๐Ÿ‡ฎ๐Ÿ‡ฑ

Hadassah Ein Kerem, Jerusalem, Israel

Use of Existing Fibroblast Cells to Convert to Induced Pluripotent Stem Cells

Recruiting
Conditions
Healthy Male Newborns
Pregnant, Healthy Females
First Posted Date
2008-12-03
Last Posted Date
2025-03-19
Lead Sponsor
Hadassah Medical Organization
Target Recruit Count
1
Registration Number
NCT00801372
Locations
๐Ÿ‡ฎ๐Ÿ‡ฑ

Hadassah Ein Kerem, Jerusalem, Israel

Water Induced Thermogenesis in Obese Children

Completed
Conditions
Obesity
Interventions
Other: Water
First Posted Date
2008-11-20
Last Posted Date
2013-08-07
Lead Sponsor
Hadassah Medical Organization
Target Recruit Count
21
Registration Number
NCT00794469
Locations
๐Ÿ‡ฎ๐Ÿ‡ฑ

Hadassah Optimal Sport Medicine Center, Jerusalem, Israel

The Influence of "Operating Table Position Simulating Radiographs" on Acetabular Cup Angle During Primary Total Hip Replacement

Not Applicable
Completed
Conditions
Hip Osteoarthritis
Interventions
Other: radiograph
First Posted Date
2008-11-11
Last Posted Date
2011-04-28
Lead Sponsor
Hadassah Medical Organization
Target Recruit Count
100
Registration Number
NCT00789048
Locations
๐Ÿ‡ฎ๐Ÿ‡ฑ

Hadassah Medical Organization, Jerusalem, Israel

Misopristol Versus Pitocin for Second Trimester Abortion

Phase 4
Completed
Conditions
Abortion, Missed
Interventions
First Posted Date
2008-11-04
Last Posted Date
2013-11-21
Lead Sponsor
Hadassah Medical Organization
Target Recruit Count
145
Registration Number
NCT00784797
Locations
๐Ÿ‡ฎ๐Ÿ‡ฑ

Hadassah Medical Organization, Jerusalem, Israel

Vascular Sensitivity to Adrenergic Agonists in Patients With CHF and in Healthy Subjects

Conditions
Congestive Heart Failure
First Posted Date
2008-10-31
Last Posted Date
2008-10-31
Lead Sponsor
Hadassah Medical Organization
Target Recruit Count
80
Registration Number
NCT00782782
Locations
๐Ÿ‡ฎ๐Ÿ‡ฑ

Hadassah University Hospital, Jerusalem, Israel

Mesenchymal Stem Cells for the Treatment of MS

Phase 1
Completed
Conditions
Multiple Sclerosis
Interventions
Biological: Injection of autologous bone marrow derived mesenchymal stem cells
First Posted Date
2008-10-29
Last Posted Date
2021-03-29
Lead Sponsor
Hadassah Medical Organization
Target Recruit Count
24
Registration Number
NCT00781872

Influenza Vaccination at a Reduced Dose Using Mesotherapy in HIV/AIDS Patients at the Hadassah AIDS Center, Jerusalem

Not Applicable
Conditions
Influenza
Acquired Immune Deficiency Syndrome
HIV Infections
Interventions
Biological: Mesotherapy
First Posted Date
2008-09-25
Last Posted Date
2008-10-09
Lead Sponsor
Hadassah Medical Organization
Target Recruit Count
100
Registration Number
NCT00758212
Locations
๐Ÿ‡ฎ๐Ÿ‡ฑ

Hadassah U. hospital, Jerusalem, Israel

Allogeneic Mesenchymal Stem Cell for Graft-Versus-Host Disease Treatment

Phase 1
Conditions
Graft-Versus-Host Disease
First Posted Date
2008-09-09
Last Posted Date
2009-08-11
Lead Sponsor
Hadassah Medical Organization
Target Recruit Count
20
Registration Number
NCT00749164
Locations
๐Ÿ‡ฎ๐Ÿ‡ฑ

Hadassah University Hospital, Jerusalem, Israel

Safety and Validation of Efficacy of Oral Administration of the Food Additive Colostrum Derived Anti Clostridium Difficile Antibodies

Phase 2
Withdrawn
Conditions
Clostridium Difficile-Associated Diarrhea
Interventions
Drug: Colostrum
First Posted Date
2008-09-04
Last Posted Date
2012-08-28
Lead Sponsor
Hadassah Medical Organization
Registration Number
NCT00747071
Locations
๐Ÿ‡ฎ๐Ÿ‡ฑ

Hadassah Medical Organization, Jerusalem, Israel

ยฉ Copyright 2025. All Rights Reserved by MedPath